Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > October 2024 Enrolment in Context
View:
Post by gebremeskel on Nov 04, 2024 1:03pm

October 2024 Enrolment in Context

At the beginning of October 2023, 74 patients had been enrolled. By the end of December 2023, 81 patients had been enrolled. So 7 patients were enrolled in 4Q23. In 4Q23 there were 20 trial sites.

Month  Patients
Enrolled
Oct. 2023 2
Nov. 2023 3
Dec. 2023 2

Enrolment picked up considerably in 1Q24 when 17 patients were enrolled. 2 more trial sites were added in 1Q24 for a total of 22 trial sites.

Month  Patients
Enrolled
Jan. 2024 6
Feb. 2024 6
Mar. 2023 5
Comment by Spamme54321 on Nov 04, 2024 1:09pm
I remember on a conference call when someone asked Dr Kellum why enrollment had increased so much in Q1 and he said he wasn't quite sure. I thought he was being modest but now I see there might have been some luck involved.
Spectral Medical Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities